Ondine Biomedical (LON:OBI) Reaches New 52-Week High – Here’s Why

Shares of Ondine Biomedical Inc. (LON:OBI) reached a new 52-week high during mid-day trading on Thursday . The company traded as high as GBX 12.50 ($0.16) and last traded at GBX 12 ($0.15), with a volume of 314113 shares. The stock had previously closed at GBX 11.50 ($0.14).

Ondine Biomedical Trading Up 3.1 %

The stock’s 50 day moving average is GBX 8.80 and its 200-day moving average is GBX 7.85. The company has a market capitalization of £35.74 million, a P/E ratio of -429.67 and a beta of 0.10. The company has a debt-to-equity ratio of 1,847.37, a current ratio of 0.80 and a quick ratio of 8.26.

Ondine Biomedical Company Profile

Ondine Biomedical is a life sciences company leading the charge in breakthrough photodisinfection-based therapies to prevent and treat serious infections, including those caused by existing, emerging, and antimicrobial-resistant pathogens.

Our vision is a world free from infections. We have created a patented, platform technology (photodisinfection) to provide simple solutions to complex infections across different therapeutic areas in healthcare and industry settings.